PT97441A - Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral - Google Patents

Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral

Info

Publication number
PT97441A
PT97441A PT97441A PT9744191A PT97441A PT 97441 A PT97441 A PT 97441A PT 97441 A PT97441 A PT 97441A PT 9744191 A PT9744191 A PT 9744191A PT 97441 A PT97441 A PT 97441A
Authority
PT
Portugal
Prior art keywords
agents
transurethral
vasodilators
administration
benzenodiois
Prior art date
Application number
PT97441A
Other languages
English (en)
Other versions
PT97441B (pt
Inventor
Virgil A Place
Robert M Gale
Rancall G Berggren
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PT97441A publication Critical patent/PT97441A/pt
Publication of PT97441B publication Critical patent/PT97441B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/16—Male reproductive, genital organs
    • A61M2210/167—Penis
PT97441A 1990-04-25 1991-04-22 Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral PT97441B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51439790A 1990-04-25 1990-04-25

Publications (2)

Publication Number Publication Date
PT97441A true PT97441A (pt) 1992-05-29
PT97441B PT97441B (pt) 1998-08-31

Family

ID=24046960

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97441A PT97441B (pt) 1990-04-25 1991-04-22 Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral

Country Status (16)

Country Link
EP (1) EP0526566B1 (pt)
JP (1) JP3477197B2 (pt)
KR (1) KR0169950B1 (pt)
AT (1) ATE173603T1 (pt)
AU (1) AU655420B2 (pt)
CA (2) CA2040914C (pt)
DE (1) DE69130529T2 (pt)
DK (1) DK0526566T3 (pt)
ES (1) ES2124225T3 (pt)
FI (1) FI104946B (pt)
IE (1) IE81089B1 (pt)
NO (1) NO300083B1 (pt)
NZ (2) NZ237899A (pt)
PT (1) PT97441B (pt)
WO (1) WO1991016021A1 (pt)
ZA (1) ZA912984B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
HUP9801324A3 (en) * 1995-03-14 1999-03-29 Vivus Inc Menlo Park Method and kit for preventing erectile dysfunction
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5855548A (en) * 1996-06-14 1999-01-05 Vivus, Incorporated Venous flow control element for maintaining penile erection
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
CA2314369A1 (en) * 1997-12-18 1999-06-24 Nathan Earl Scott Prostaglandin e2/f2.alpha. combination for treating impotence and enhancing sexual arousal
ES2155740B1 (es) * 1998-03-31 2001-12-01 Vita Invest Sa Dispositivo intrauretral para el tratamiento de la disfuncion erectil.
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
CA2353613A1 (en) * 1998-12-02 2000-06-08 Shigeharu Suzuki Preparations for intraurethral administration
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US7176238B1 (en) 1999-03-01 2007-02-13 Nitromed Inc. Nitrostated and nitrosylated prostaglandins, compositions and methods of use
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
KR20150089085A (ko) 2007-02-12 2015-08-04 브릭스 파마슈티컬스 인코퍼레이티드 조루 및 발기부전을 동시에 치료하는 방법
WO2008100933A2 (en) 2007-02-12 2008-08-21 Dmi Biosciences, Inc. Reducing side effects of tramadol
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
AU2016205336A1 (en) 2015-01-06 2017-08-03 Venturis Therapeutics, Inc. Angiogenic treatment of ischemic heart disease
WO2016133848A2 (en) 2015-02-16 2016-08-25 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US10653549B2 (en) * 2017-07-18 2020-05-19 Carl W. Lange, IV Topical medication method for erectile dysfunction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1897423A (en) * 1928-10-30 1933-02-14 Ferri Filiberto Device for preventing gonorrhea infection
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen

Also Published As

Publication number Publication date
NZ270871A (en) 1999-05-28
AU7856391A (en) 1991-11-11
JP3477197B2 (ja) 2003-12-10
NO924032D0 (no) 1992-10-19
CA2352552C (en) 2008-12-02
NO300083B1 (no) 1997-04-07
EP0526566B1 (en) 1998-11-25
FI924817A (fi) 1992-10-23
DE69130529D1 (de) 1999-01-07
CA2040914A1 (en) 1991-10-26
AU655420B2 (en) 1994-12-22
NZ237899A (en) 1997-03-24
WO1991016021A1 (en) 1991-10-31
EP0526566A1 (en) 1993-02-10
KR930700048A (ko) 1993-03-13
CA2352552A1 (en) 1991-10-26
DK0526566T3 (da) 1999-08-09
ZA912984B (en) 1992-01-29
FI104946B (fi) 2000-05-15
ATE173603T1 (de) 1998-12-15
NO924032L (no) 1992-10-26
CA2040914C (en) 2001-12-04
PT97441B (pt) 1998-08-31
DE69130529T2 (de) 1999-06-02
KR0169950B1 (ko) 1999-01-15
IE911330A1 (en) 1991-11-06
ES2124225T3 (es) 1999-02-01
IE81089B1 (en) 2000-03-08
FI924817A0 (fi) 1992-10-23
JPH05506800A (ja) 1993-10-07

Similar Documents

Publication Publication Date Title
PT97441A (pt) Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral
PT782448E (pt) Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes
DK0436217T3 (da) Antiinflammatorisk analgetisk plaster
PE20010924A1 (es) Compuestos inhibidores de fosfodiesterasa utiles para el tratamiento de la disfuncion sexual femenina
BR9917299A (pt) Composição tópica e uso de uma composição tópica
SE8601246D0 (sv) Utvendig kateter for men och paforingskrage for denna
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
AR021912A1 (es) Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones
HRP20030024A2 (en) Method for the treatment of climacteric disorders in women or after the menopause
BR9809571A (pt) Composição medicinal e processo para produzì-la
WO1999030718A3 (en) PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL
BR9800718B1 (pt) composto esteróide tendo atividade contraceptiva, anti-osteoporose e para prevenir e tratar queixas da menopausa, composição farmacêutica, uso de um composto esteróide, e, processo para a preparação de um esteróide 16, 17 anelado.
IT1247678B (it) Metodo per la cura dell'impotenza erettiva maschile
ES2065673T3 (es) Procedimiento para aumentar la fertilidad en las hembras.
FR2444463A1 (fr) Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
KR880004810A (ko) 소화성 궤양 치료제
ATE233085T1 (de) Arzneimittel zur topischen anwendung
BR9611671A (pt) Método de alvejamento de dosagens de medicamentos e de agentes terapêuticos e de outros glicosaminoglicanos (gags) para tratar de uma doença ou condição em um ser humano.
BE894860A (fr) Therapeutique adjuvante par agent progestatif
PT98256A (pt) Processo para a obtencao de um preparado farmaceutico, para aplicacao vaginal, contendo um alcool polivinilico
Khosla et al. Effect of therapeutic agents on acute ocular toxicity of methyl alcohol (an experimental study)
PT1347753E (pt) Composicao topica e metodo para o tratamento da incontinencia urinaria de stress
ATE155041T1 (de) Rectale pharmazeutische zubereitung fuer die behandlung von prostataanschwellung
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920124

FG3A Patent granted, date of granting

Effective date: 19980511

PC3A Transfer or assignment

Free format text: 19981218 VIVUS, INC. US

PC4A Transfer of assignment

Owner name: MEDA AB, SE

Effective date: 20110209

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130513